Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients

Mathieu Anheim, B. Monga, Marie‐Céline Fleury, +31

Brain

The <i>PTPN22</i> 620W allele is a risk factor for Wegener's granulomatosis

Peter Jagiello, Peer Aries, Larissa Arning, +5

Arthritis & Rheumatism

Efficacy of Fumaric Acid Esters in the R6/2 and YAC128 Models of Huntington's Disease

Gisa Ellrichmann, Elisabeth Petrasch‐Parwez, De-Hyung Lee, +5

PLoS ONE

New genomic region for Wegener?s granulomatosis as revealed by an extended association screen with 202 apoptosis-related genes

Peter Jagiello, Martin Genčík, Larissa Arning, +5

Human Genetics

Extended Association ScreenAutoimmune DiseaseNew Genomic RegionMedicineGranulocyte +13

PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease

Elahe Taherzadeh-Fard, Carsten Saft, Denis A. Akkad, +5

Molecular Neurodegeneration

Patterns of CAG repeat instability in the central nervous system and periphery in Huntington’s disease and in spinocerebellar ataxia type 1

Ricardo Mouro Pinto, Larissa Arning, James V. Giordano, +21

Human Molecular Genetics

Neurological DisorderGeneticsSynaptic SignalingSocial SciencesSomatic Expansion +16

NR2A and NR2B receptor gene variations modify age at onset in Huntington disease

Larissa Arning, Peter H. Kraus, Sandra Valentin, +3

Neurogenetics

Alzheimer's DiseaseGeneticsDegenerative DiseaseHuntington DiseaseDegenerative Pathology +5

Handedness and the X chromosome: The role of androgen receptor CAG-repeat length

Larissa Arning, Sebastian Ocklenburg, Stefanie Schulz, +7

Scientific Reports

Functionally relevant variations of the interleukin‐10 gene associated with antineutrophil cytoplasmic antibody–negative Churg‐Strauss syndrome, but not with Wegener's granulomatosis

Stefan Wieczorek, Bernhard Hellmich, Larissa Arning, +4

Arthritis & Rheumatism

PGC-1alphaas modifier of onset age in Huntington disease

Elahe Taherzadeh-Fard, Carsten Saft, Jürgen Andrich, +2

Molecular Neurodegeneration